P. M. Houtman

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

Suzanne Arends, Elisabeth Brouwer, E. van der Veer et al. · Arthritis Research & Therapy · 2011 · 227 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +11

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients

M.K. Reinders, Eric N. van Roon, P. M. Houtman et al. · Clinical Rheumatology · 2007 · 91 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.

P. M. Houtman, Cornelis Kallenberg, Fidler et al. · PubMed · 1986 · 90 citations

Medicine, Pathology, Dermatopathology +10

Hepatic injury caused by benzbromarone

Melanie M. van der Klauw, P. M. Houtman, Bruno H. Stricker et al. · Journal of Hepatology · 1994 · 81 citations

Pharmacy, Pharmacology, Toxicology +12

Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments

Suzanne Arends, M. Hofman, Y.P.T. Kamsma et al. · Arthritis Research & Therapy · 2013 · 62 citations · Full text

Education, Kinesiology, Physical Activity +10